Documente Academic
Documente Profesional
Documente Cultură
Pharmacological Department
Medical School UNPAD
Ike Husen
ADRENERGIC DRUGS
Affect receptors which are stimulated by
NE (noradrenalin) & E (adrenalin)
Adrenergic drugs
Agonist
(sympathomimetic agents)
Antagonists
(sympatholytic agents)
SYNTHESIS OF NE
Tyr
Tirosin hidroksilase
DOPA
Tyr
Inactive
metabolite
Inhibitor:
1= reserpine
2= guanethidine
bretylium
METABOLISM
Dopamine
1
uptake
VESICLES:
Dopamine
dopamine--hydroxylase
REMOVAL OF NE
Inhibitor: cocaine &
imipramine
NE
2
release
BINDING TO
RECEPTOR
Intracellular
response
Adrenoreceptor
Vasoconst.
(+) Inotropic
Periph. resist.
(+) Chronotropic
BP
lipolysis
Mydriasis
Closure internal
sphincter bladder
Vasodilatation
Slightly periph.
Resist.
Inhibition of NE
release
Bronchodilatation
Inhibition of
insulin release
release of glucagon
Glycogenolysis
Relaxed uterine
smooth musc.
Receptor
Specificit
y
Drug
Receptor
Specificit
y
Epinephrine*
1, 2
1, 2
Phenylephrin
e
Norepinephrin
e*
1, 2
1
Methoxamin
e
Isoproterenol*
1, 2
Clonidine
Dopamine*
Dopaminergi
c
1, 2
Dobutamine*
* : Cathecolamine
Metaproteren
ol
Turbetaline
Ritodrin
Albuterol
2> 1
EPINEPHRINE
and
Low doses : - predominant on vasc. syst.
High doses : - predominant on vasc. syst.
CO
O2 consumption
EPINEPHRINE ACTION
Respiratory ( 2 ) :
( 3 ?)
Biotransformations
COMT (catechol-O-methyl transferase) MAO
Metabolites
THERAPEUTIC USES
Bronchospasm:
glaucoma
In anesthetics : local
DOA
PHARMACOKINETICS
Rapid OOA
Brief DOA
Administration :
Sc.
Inhalation
Topical
ADVERSE EFFECTS
CNS
Hemorrhage:cerebral
Cardiac
arrhytmias
Pulmonary
edema
hemorrhages
NOREPINEPHRINE
Bradycardia (baroreflex: )
Therapeutic
uses: (levarterenol)
Shock (RBF: )
ISOPROTERENOL ( 1 and 2 )
CVS:
DOPAMINE
1 and
Cardiac
AR:
ADRENERGIC ANTAGONISTS
(SYMPATHOLYTICS)
Antagonists
Classification
-BLOCKERS
-BLOCKERS
Phenoxybenzamine
Propanolol
Phentolamine
Timolol
Prazosin
Acebutolol
Terazosin
Metoprolol
Doxazosin
Pindolol
Labetalol
DRUGS AFFECTING
NEUROTRANSMITTER
UPTAKE/RELEASE
Carvedilol
Adverse effect:
Orthostatic hypotension
Tachycardia
Fatigue
Sexual disturbances
PHENTOLAMINE
Competitive -blockers (4hrs)
Th/ uses:
Frostbite
Sex. Dysfunction (male)
AR:
Tachycardia
Postural hypotension
GI stimulation
Therapeutic uses
Hypertension
( CO)
Glaucoma: IOP ( the secretion of
aqueous H.)
Migraine: reducing migraine episodes
Hyperthyroidsm (protecting cardiac
arrhythmias)
Angina pectoris
Myocardial infarction
Adverse effect
Bronchoconstriction
Arrhythmias
(rapid withdrawal)
Sexual impairment (pathogen. ???)
Disturbances in glucose metabolism
Other : TAG level
Timolol
-blocker
the secretion of aqueous Humor
Therapeutics uses:
Topical: glaucoma
Systemic: Hypertension
Nonselective
Acebutolol, atenolol,and
metoprolol
Decrease BP
Increase exercise tolerance in angina
Therapeutic use in hypertension, espec.:
Diabetic hypertensive patients who are
receiving insulin or oral hypoglycemic
agents
Receptor
Cell. effect
Antagonist
blocked
Partial Agonist
Cell. effect
antagonists agents
partial agonists agents
Actions:
Therapeutic
uses in hypertension:
Hypertension with moderate
bradycardia
Hypertension patients whom
taking hypoglycemic agents
Hypertensive athletes